PDCD1 and B-cell non-Hodgkin lymphoma: In patients with DLBCL, LAG-3 is highly expressed on CD4+ Tregs and CD8+ TILs, while its co-expression with PD-1 and TIM-3 has also been observed on certain B-cell lymphomas.